ResearchMoz

Respiratory Devices Market Research Reports & Industry Analysis

Respiratory Devices Market Research Reports & Industry Analysis Respiratory Devices

Browse reports in Respiratory Devices

Displaying 1 to 30 (of 57 records)
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) - Opportunity Analysis and Forecasts to 2017
Apr 2013   |   By - GlobalData
OpportunityAnalyzer: Idiopathic Pulmonary Fibrosis (IPF) Opportunity Analysis and Forecasts to 2017 Summary Idiopathic Pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause. Limited to the lungs it occurs primarily in older adults =50 years old, with an abysmal prognosis (3-5 years following diagnosis). After...
$5995
OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017
Apr 2013   |   By - GlobalData
OpportunityAnalyzer: Cystic Fibrosis Therapeutics Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break...
$5995
Acute Respiratory Distress Syndrome - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Acute Respiratory Distress Syndrome Pipeline Review, H1 2013 Summary Global Markets Directs, 'Acute Respiratory Distress Syndrome Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Respiratory Distress Syndrome, complete with latest updates, and special...
$2000
Bronchiectasis - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Bronchiectasis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Bronchiectasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchiectasis, complete with latest updates, and special features on late -stage and discontinued projects. It also...
$2000
Lung Disease - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Lung Disease Pipeline Review, H1 2013 Summary Global Markets Directs, 'Lung Disease Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lung Disease, complete with latest updates, and special features on late -stage and discontinued projects. It also reviews key...
$2000
Perennial Allergic Rhinitis - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Perennial Allergic Rhinitis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Perennial Allergic Rhinitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Perennial Allergic Rhinitis, complete with latest updates, and special features on late -stage...
$2000
Respiratory Tract Inflammatory Disorders - Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Respiratory Tract Inflammatory Disorders Pipeline Review, H1 2013 Summary Global Markets Directs, 'Respiratory Tract Inflammatory Disorders Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Tract Inflammatory Disorders, complete with latest...
$2000
Prostate Cancer Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Prostate Cancer Pipeline Review, H1 2013 Summary Global Markets Directs, 'Prostate Cancer Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Prostate Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2500
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Pipeline Review, H1 2013 Summary Global Markets Directs, 'Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Acute Myelocytic Leukemia...
$2000
Candidiasis Pipeline Review, H1 2013
Mar 2013   |   By - Global Markets Direct
Candidiasis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Candidiasis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key...
$2000
Chronic Bronchitis - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Chronic Bronchitis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Chronic Bronchitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Chronic Bronchitis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Lung Infections - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Lung Infections Pipeline Review, H1 2013 Summary Global Markets Directs, 'Lung Infections Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Lung Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Allergic Rhinitis - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Allergic Rhinitis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Allergic Rhinitis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Allergic Rhinitis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2013
Feb 2013   |   By - Global Markets Direct
Idiopathic Pulmonary Fibrosis Pipeline Review, H1 2013 Summary Global Markets Directs, 'Idiopathic Pulmonary Fibrosis Pipeline Review, H1 2013', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Idiopathic Pulmonary Fibrosis, complete with latest updates, and special features on...
$2000
Laerdal Medical AS Market Share Analysis
Feb 2013   |   By - GlobalData
Laerdal Medical AS Market Share Analysis Summary GlobalDatas new report, Laerdal Medical AS Market Share Analysis provides in-depth information on Laerdal Medical ASs market position in the different medical equipment markets it operates in. The report provides Laerdal Medical AS market share information in two key market categories Respiratory Disposables and...
$1000
K. Takaoka Industria e Comercio Ltda. Market Share Analysis
Feb 2013   |   By - GlobalData
K. Takaoka Industria e Comercio Ltda. Market Share Analysis Summary GlobalDatas new report, K. Takaoka Industria e Comercio Ltda. Market Share Analysis provides in-depth information on K. Takaoka Industria e Comercio Ltda.s market position in the different medical equipment markets it operates in. The report provides K. Takaoka Industria e Comercio Ltda. market...
$1000
Bronchiectasis Global Clinical Trials Review, H1, 2013
Feb 2013   |   By - GlobalData
Bronchiectasis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Bronchiectasis Global Clinical Trials Review, H1, 2013" provides data on the Bronchiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchiectasis. It includes an overview of the trial numbers and...
$2500
Asthma Global Clinical Trials Review, H1, 2013
Jan 2013   |   By - GlobalData
Asthma Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, Asthma Global Clinical Trials Review, H1, 2013" provides data on the Asthma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Asthma. It includes an overview of the trial numbers and their recruitment status as per...
$2500
SOMNOmedics GmbH Market Share Analysis
Jan 2013   |   By - GlobalData
SOMNOmedics GmbH Market Share Analysis Summary GlobalDatas new report, SOMNOmedics GmbH Market Share Analysis provides in-depth information on SOMNOmedics GmbH.s market position in the anesthesia and respiratory devices market. The report also provides data and information on the overall competitive landscape within the anesthesia and respiratory devices market....
$1000
Pulmonary Fibrosis Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Pulmonary Fibrosis Pipeline Review, H2 2012 Summary Global Markets Directs, 'Pulmonary Fibrosis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It...
$2000
Bronchiolitis Obliterans Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Bronchiolitis Obliterans Pipeline Review, H2 2012 Summary Global Markets Directs, 'Bronchiolitis Obliterans Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and...
$2000
Respiratory Tract Inflammatory Disorders Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Respiratory Tract Inflammatory Disorders Pipeline Review, H2 2012 Summary Global Markets Directs, 'Respiratory Tract Inflammatory Disorders Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Tract Inflammatory Disorders, complete with latest...
$2500
Respiratory Tract Infections Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Respiratory Tract Infections Pipeline Review, H2 2012 Summary Global Markets Directs, 'Respiratory Tract Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Respiratory Tract Infections, complete with latest updates, and special features on late-stage...
$2000
Allergic Asthma Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Allergic Asthma Pipeline Review, H2 2012 Summary Global Markets Directs, 'Allergic Asthma Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Allergic Asthma, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Bacterial Respiratory Tract Infections Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Bacterial Respiratory Tract Infections Pipeline Review, H2 2012 Summary Global Markets Directs, 'Bacterial Respiratory Tract Infections Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bacterial Respiratory Tract Infections, complete with latest updates, and...
$2000
Pleural Disease Pipeline Review, H2 2012
Nov 2012   |   By - Global Markets Direct
Pleural Disease Pipeline Review, H2 2012 Summary Global Markets Directs, 'Pleural Disease Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Pleural Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also...
$2000
Diphtheria Pipeline Review, H2 2012
Oct 2012   |   By - Global Markets Direct
Diphtheria Pipeline Review, H2 2012 Global Markets Directs, 'Diphtheria Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Diphtheria, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the...
$2000
Bronchiolitis Pipeline Review, H2 2012
Oct 2012   |   By - Global Markets Direct
Bronchiolitis Pipeline Review, H2 2012 Global Markets Directs, 'Bronchiolitis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved...
$2000
Bronchopulmonary Dysplasia Pipeline Review, H2 2012
Oct 2012   |   By - Global Markets Direct
Bronchopulmonary Dysplasia Pipeline Review, H2 2012 Global Markets Directs, 'Bronchopulmonary Dysplasia Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Bronchopulmonary Dysplasia, complete with latest updates, and special features on late-stage and discontinued...
$2000
Cystic Fibrosis Pipeline Review, H2 2012
Oct 2012   |   By - Global Markets Direct
Cystic Fibrosis Pipeline Review, H2 2012 Global Markets Directs, 'Cystic Fibrosis Pipeline Review, H2 2012', provides an overview of the indications therapeutic pipeline. This report provides information on the therapeutic development for Cystic Fibrosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players...
$2000
 
Displaying 1 to 30 (of 57 records)